ES2181446T3 - Composicion sinergica para usar en el tratamiento del cancer. - Google Patents

Composicion sinergica para usar en el tratamiento del cancer.

Info

Publication number
ES2181446T3
ES2181446T3 ES99924999T ES99924999T ES2181446T3 ES 2181446 T3 ES2181446 T3 ES 2181446T3 ES 99924999 T ES99924999 T ES 99924999T ES 99924999 T ES99924999 T ES 99924999T ES 2181446 T3 ES2181446 T3 ES 2181446T3
Authority
ES
Spain
Prior art keywords
cancer
treatment
composition
synergic composition
inulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99924999T
Other languages
English (en)
Inventor
Henryk Taper
Anne Frippiat
Loo Jan Van
Marcel Roberfroid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tiense Suikerraffinaderij NV
Original Assignee
Tiense Suikerraffinaderij NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tiense Suikerraffinaderij NV filed Critical Tiense Suikerraffinaderij NV
Application granted granted Critical
Publication of ES2181446T3 publication Critical patent/ES2181446T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición farmacéutica caracterizada porque comprende una combinación de una dosis efectiva de inulina y de un fármaco anticancerígeno antimetabólico.
ES99924999T 1998-05-18 1999-05-18 Composicion sinergica para usar en el tratamiento del cancer. Expired - Lifetime ES2181446T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98870113A EP0958825A1 (en) 1998-05-18 1998-05-18 Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer

Publications (1)

Publication Number Publication Date
ES2181446T3 true ES2181446T3 (es) 2003-02-16

Family

ID=8237043

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99924999T Expired - Lifetime ES2181446T3 (es) 1998-05-18 1999-05-18 Composicion sinergica para usar en el tratamiento del cancer.

Country Status (7)

Country Link
EP (2) EP0958825A1 (es)
AT (1) ATE225179T1 (es)
DE (1) DE69903283T2 (es)
DK (1) DK1079840T3 (es)
ES (1) ES2181446T3 (es)
PT (1) PT1079840E (es)
WO (1) WO1999059600A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1125507A1 (en) * 2000-02-15 2001-08-22 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Inulin products with improved nutritional properties
EP1428528A1 (en) * 2002-09-27 2004-06-16 Tiense Suikerraffinaderij N.V. Synergistic combinations of dietary fiber and NSAIDs for the treatment of cancer
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
JP2008503583A (ja) * 2004-06-22 2008-02-07 プロ−ファーマシューティカルズ，インコーポレイティド 抗がん薬、抗血管形成薬、及び多糖類を共デリバリーするための組成物及び方法
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CA2793485A1 (en) 2010-03-29 2011-10-06 Ferring B.V. A fast dissolving pharmaceutical composition
WO2013037708A1 (en) 2011-09-16 2013-03-21 Ferring B.V. A fast dissolving pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69520528T2 (de) * 1994-06-14 2001-09-27 Raffinerie Tirlemontoise Sa Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel

Also Published As

Publication number Publication date
PT1079840E (pt) 2002-12-31
WO1999059600A1 (en) 1999-11-25
DE69903283D1 (de) 2002-11-07
DE69903283T2 (de) 2003-02-13
EP1079840B1 (en) 2002-10-02
ATE225179T1 (de) 2002-10-15
DK1079840T3 (da) 2002-11-04
EP0958825A1 (en) 1999-11-24
EP1079840A1 (en) 2001-03-07

Similar Documents

Publication Publication Date Title
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
PA8528401A1 (es) Derivados de quinolina y quinazolina
BR0312286A (pt) pró-medicamentos de 2' e 3' - nucleosìdeo modificado para tratamento de infecções por flaviviridae
BR0114310A (pt) Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos
BR0008447A (pt) Métodos de tratamento de distúrbios mitocondriais
EA200900626A1 (ru) Комбинированное лечение ингибиторами sglt-2 (натрийзависимый сопереносчик глюкозы 2) и содержащими их фармацевтическими композициями
BR0208563A (pt) composições de n-acetilcisteìna e métodos para o tratamento e prevenção de toxidade de droga
CY1107615T1 (el) Θεραπευτικοι συνδυασμοι αντιυπερτασικων και αντιαγγειογενετικων παραγοντων
NO20100302L (no) Sammensetninger som inneholder organiske forbindelser
AR019855A1 (es) Uso de conjugados de peg-ifn-alfa y ribavirina para la fabricacion de un medicamento para el tratamiento de hepatitis c cronica
AR027355A1 (es) Acidos tiazolidincarboxilicos
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
DK1401458T3 (da) Sammensætning bestående af PHY906 og kemoterapeutiske midler
ES2181446T3 (es) Composicion sinergica para usar en el tratamiento del cancer.
TNSN05065A1 (en) Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
UY27018A1 (es) Derivados de la pirimidina
BR0215935A (pt) Terapia combinada para tratamento de leucemia aguda e sìndrome mielodisplásica
CY1114686T1 (el) Χρηση toy ck2 αναστολεα για την θεραπεια και χημειοευαισθητοποιηση των ανθεκτικων σε αντικαρκινικα φαρμακα ογκων
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
SE0401871D0 (sv) New compositions
BR0211936A (pt) Uso de glicosamina e de um inibidor seletivo para ciclooxigenase-2, ou de pró-droga dos mesmos, na fabricação de um medicamento, bem como composição farmacêutica e kit compreendendo os mesmos
BRPI0414518A (pt) composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano
BR0017329A (pt) Formulção farmacêutica de um medicamento, uso de melatonina na fabricação de um medicamento, e, método para prevenção ou tratamento de sintomas de discinesia tardia em um paciente usanto tal medicamento
BR0114389A (pt) Terapia antitumor que inclui derivado de distamicina